Identification of miR-143 as a Major Contributor for Human Stenotic Aortic Valve Disease.


Journal

Journal of cardiovascular translational research
ISSN: 1937-5395
Titre abrégé: J Cardiovasc Transl Res
Pays: United States
ID NLM: 101468585

Informations de publication

Date de publication:
10 2019
Historique:
received: 15 11 2018
accepted: 26 02 2019
pubmed: 7 3 2019
medline: 2 6 2020
entrez: 7 3 2019
Statut: ppublish

Résumé

Calcification of aortic valves leads to aortic stenosis mainly in elderly individuals, but the underlying molecular mechanisms are still not understood. Here, we studied microRNA (miR, miRNA) expression and function in healthy and stenotic human aortic valves. We identified miR-21, miR-24, and miR-143 to be highly upregulated in stenotic aortic valves. Using luciferase reporter systems, we found direct binding of miR-143 to the 3'UTR region of the matrix gla protein (MGP), which in turn is a key factor to sustain homeostasis in aortic valves. In subsequent experiments, we demonstrated a therapeutic potential of miRNA regulation during calcification in cardiac valvular interstitial cells. Collectively, our data provide evidence that deregulated miR expression contributes to the development of stenotic valve disease and thus form novel therapeutic opportunities of this severe cardiovascular disease.

Identifiants

pubmed: 30840186
doi: 10.1007/s12265-019-09880-7
pii: 10.1007/s12265-019-09880-7
doi:

Substances chimiques

3' Untranslated Regions 0
Calcium-Binding Proteins 0
Extracellular Matrix Proteins 0
MIRN143 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

447-458

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : KFO311
Pays : International
Organisme : EraNet
ID : Expert
Pays : International

Références

Nature. 2008 Dec 18;456(7224):980-4
pubmed: 19043405
J Biol Chem. 2017 May 26;292(21):8657-8666
pubmed: 28377507
J Clin Invest. 2009 Sep;119(9):2634-47
pubmed: 19690389
J Am Coll Cardiol. 2006 Aug 1;48(3):e1-148
pubmed: 16875962
Circ Res. 2013 Jul 5;113(2):179-85
pubmed: 23833292
Circulation. 2011 Aug 9;124(6):720-30
pubmed: 21788589
Nature. 1997 Mar 6;386(6620):78-81
pubmed: 9052783
J Heart Valve Dis. 2011 May;20(3):284-91
pubmed: 21714418
Cell Stem Cell. 2017 Feb 2;20(2):218-232.e5
pubmed: 27867037
Cell. 2005 Jan 14;120(1):15-20
pubmed: 15652477
JACC Cardiovasc Imaging. 2013 Feb;6(2):137-46
pubmed: 23489526
Nature. 2009 Aug 6;460(7256):705-10
pubmed: 19578358
Circulation. 2012 Jan 3;125(1):76-86
pubmed: 22090163
Prog Cardiovasc Dis. 2014 May-Jun;56(6):565-71
pubmed: 24838132

Auteurs

Jan Fiedler (J)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. fiedler.jan@mh-hannover.de.

Da-Hee Park (DH)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Integrated Research and Treatment Center Transplantation, Hannover Medical School, Hannover, Germany.

Lisa Hobuß (L)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Parnian Kalbasi Anaraki (PK)

Department of Nephrology, Hannover Medical School, Hannover, Germany.

Angelika Pfanne (A)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Annette Just (A)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Integrated Research and Treatment Center Transplantation, Hannover Medical School, Hannover, Germany.

Saskia Mitzka (S)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Inna Dumler (I)

Department of Nephrology, Hannover Medical School, Hannover, Germany.

Frank Weidemann (F)

Department of Cardiology, Klinikum Vest, Recklinghausen, Germany.

Andres Hilfiker (A)

Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Hannover Medical School, Hannover, Germany.

Thomas Thum (T)

Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. thum.thomas@mh-hannover.de.
Integrated Research and Treatment Center Transplantation, Hannover Medical School, Hannover, Germany. thum.thomas@mh-hannover.de.
National Heart and Lung Institute, Imperial College London, London, UK. thum.thomas@mh-hannover.de.
REBIRTH Excellence Cluster, Hannover Medical School, Hannover, Germany. thum.thomas@mh-hannover.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH